Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutations.

The first standard of care in treatment of chronic HCV genotype 1 infection involving directly acting antivirals was protease inhibitors telaprevir or boceprevir combined with pegylated-interferon and ribavirin (triple therapy). Phase III studies include highly selected patients. Thus, treatment res...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Christina Sølund, Henrik Krarup, Santseharay Ramirez, Peter Thielsen, Birgit T Røge, Suzanne Lunding, Toke S Barfod, Lone G Madsen, Britta Tarp, Peer B Christensen, Jan Gerstoft, Alex L Laursen, Jens Bukh, Nina Weis, DANHEP group
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science (PLoS) 2014-01-01
Edice:PLoS ONE
On-line přístup:http://europepmc.org/articles/PMC4249835?pdf=render
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky